Local market size for oncology and hormone-based products is estimated at EGP1.5bn, which is currently 100% imported
Latest in Tag: EIPICO Highlight
Latest in Tag: EIPICO
EIPICO produces 18% of antibiotics available in Egyptian market
Company plans to inaugurate three production lines in Q1 of 2021
A source has revealed that the Egyptian pharmaceutical company, EIPICO, plans to invest about EGP 800m over the next three years, directed towards re-modelling and renewing the machinery at its facilities. The financing will not be directed to its biosimilar project.
The countries that will receive the Egyptian manufactured vaccine are Russia, Ukraine, Kazakhstan, Uzbekistan, Moldova, Belarus, Kurdistan, Tajikistan, Poland, the Czech Republic, and Slovakia.
Pharmaceutical company underperformed on market, reporting aggressive 31% decline in retail sales
The production of the drug comes after EIPICO received approval from the Egyptian Drug Authority (EDA).
Company’s operations suffered from traffic disruption, interruption of shipping and export operations
New financial adviser appointed to assess fair value of deal before sending required documents to FRA
The delayed development plans include recently announced new activities due to directing the dollar’s resources to the import of raw materials, says head of financial division